SEC Comment Letter for CASSAVA SCIENCES INC (FLNA) (CIK 0001069530) (FLNA) — Aug 14, 2023

CASSAVA SCIENCES INC (FLNA) (CIK 0001069530)
Date: Aug. 14, 2023 · CIK: 0001069530 · Accession: 0000000000-23-008808

View on Edgar

AI Filing Summary & Sentiment

Sentiment

Urgency

Document Type

Confidence

SEC Posture

Company Posture

Summary

Reasoning

File numbers found in text: 000-29959

Date

August 14, 2023

Author

Eric Schoen

Form

UPLOAD

Company

CASSAVA SCIENCES INC (FLNA) (CIK 0001069530)

Letter

United States securities and exchange commission logo August 14, 2023 Eric Schoen Chief Financial Officer Cassava Sciences, Inc. 6801 N. Capital of Texas Highway, Building 1, Suite 300 Austin, TX 78731 Re:Cassava Sciences, Inc. Form 10-K for the Fiscal Year Ended December 31, 2022 Filed February 28, 2023 File No. 000-29959 Dear Eric Schoen: We have completed our review of your filings. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Sincerely, Division of Corporation Finance Office of Life Sciences

Show Raw Text

United States securities and exchange commission logo
August 14, 2023
Eric Schoen
Chief Financial Officer
Cassava Sciences, Inc.
6801 N. Capital of Texas Highway, Building 1, Suite 300
Austin, TX 78731
Re:Cassava Sciences, Inc.
Form 10-K for the Fiscal Year Ended December 31, 2022
Filed February 28, 2023
File No. 000-29959
Dear Eric Schoen:
            We have completed our review of your filings.  We remind you that the company and its
management are responsible for the accuracy and adequacy of their disclosures, notwithstanding
any review, comments, action or absence of action by the staff.
Sincerely,
Division of Corporation Finance
Office of Life Sciences

SecProbe.io